Legumain Knockout Protects Against Aβ1-42-Induced AD-like Cognitive Deficits and Synaptic Plasticity Dysfunction Via Inhibiting Neuroinflammation Without Cleaving APP.

Molecular Neurobiology
Runwen ChenTao Zhang

Abstract

Neuroinflammation is the important pathological feature of Alzheimer's disease (AD). Legumain, a lysosomal cysteine protease, plays an important role in neuroinflammation during ischemic stroke and depressive disorder. Legumain is involved in AD process through cleaving APP; however, it is unclear if legumain can possibly modulate neuroinflammation without cleaving APP in AD. Thus, we established a mouse model of AD by single intracerebroventricular injections of Aβ1-42 in legumain knockout (KO) mice. The behavioral tests showed that legumain-KO effectively ameliorated cognitive impairment induced by Aβ1-42. Moreover, legumain deprivation significantly improves the synaptic plasticity damages in Aβ1-42-treated mice. Moreover, legumain-KO considerably inhibited the activation of microglia and reduced the expression of inflammatory cytokines in the hippocampus of Aβ1-42-treated mice. Interestingly, we found that legumain-KO inhibited TLR4/MyD88/NF-κB pathway, which was activated by Aβ1-42 in the hippocampus. In conclusion, our results suggested that legumain-KO reduced the level of neuroinflammation that was associated with inhibiting TLR4/MyD88/NF-κB pathways, thereby improving the hippocampal synaptic plasticity and reducing th...Continue Reading

References

Jan 1, 1987·Annual Review of Neuroscience·T J Teyler, P DiScenna
Sep 18, 1999·Science·R C Malenka, R A Nicoll
Jan 22, 2002·Trends in Neurosciences·Amritpal Mudher, Simon Lovestone
May 8, 2002·Nature Reviews. Neuroscience·Minh Dang NguyenSerge Rivest
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Ron Strohmeyer, Joseph Rogers
Nov 15, 2002·Journal of Neuropathology and Experimental Neurology·Malika BsibsiJohannes M van Noort
Dec 12, 2002·Journal of Neurovirology·Patrick L McGeer, Edith G McGeer
Jun 26, 2004·Annual Review of Neuroscience·Larry R SquireRobert E Clark
Aug 6, 2005·Progress in Neurobiology·Michelle L Block, Jau-Shyong Hong
Feb 13, 2007·Neuroscience·M LetiembreK Fassbender
Jul 7, 2007·Sub-cellular Biochemistry·Christine A SzekelyPeter P Zandi
Nov 6, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Silke WalterKlaus Fassbender
Aug 15, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Suzanne E HickmanJoseph El Khoury
Oct 18, 2008·Journal of Neuroinflammation·Melissa K McCoy, Malú G Tansey
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiaoyang WangCarina Mallard
Mar 18, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Taku IshizakiKarsten Ruscher
Nov 19, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masashi KitazawaFrank M LaFerla
Dec 27, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shirong LiuKlaus Fassbender
Jul 16, 2013·Neurobiology of Learning and Memory·Gary P MorrisBryce Vissel
Apr 27, 2016·Expert Opinion on Therapeutic Targets·Zhentao ZhangKeqiang Ye
Feb 27, 2017·Ageing Research Reviews·Mahban RahimifardSeyed Fazel Nabavi
Jul 4, 2017·Nature Structural & Molecular Biology·Zhentao ZhangKeqiang Ye
Jan 25, 2018·CNS Neuroscience & Therapeutics·Nofar TorikaSigal Fleisher-Berkovich
Feb 28, 2018·Alzheimer's Research & Therapy·Frederic BrosseronMichael T Heneka
Sep 12, 2019·Behavioural Brain Research·Jianxing LianZhuo Yang

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
genotyping
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.